Acrivon Therapeutics, Inc. (ACRV)
2.10
+0.04
(+1.94%)
USD |
NASDAQ |
Aug 31, 16:00
2.05
-0.05
(-2.38%)
After-Hours: 17:59
Acrivon Therapeutics Price : 2.10 for Aug. 31, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Aug 28, 2026 | 2.16 | 2.190 | 2.05 | 2.06 | 217930.0 |
| Aug 27, 2026 | 2.11 | 2.20 | 2.08 | 2.15 | 188355.0 |
| Aug 26, 2026 | 2.17 | 2.19 | 2.08 | 2.08 | 160131.0 |
| Aug 25, 2026 | 2.19 | 2.255 | 2.17 | 2.18 | 243113.0 |
| Aug 24, 2026 | 2.19 | 2.225 | 2.06 | 2.20 | 171493.0 |
| Aug 21, 2026 | 2.21 | 2.31 | 2.18 | 2.21 | 361333.0 |
| Aug 20, 2026 | 2.33 | 2.37 | 2.17 | 2.20 | 499428.0 |
| Aug 19, 2026 | 2.06 | 2.39 | 2.06 | 2.39 | 731493.0 |
| Aug 18, 2026 | 2.05 | 2.065 | 1.97 | 2.05 | 336372.0 |
| Aug 17, 2026 | 2.11 | 2.14 | 1.96 | 2.05 | 1.501M |
| Aug 14, 2026 | 1.90 | 1.99 | 1.85 | 1.95 | 758082.0 |
| Aug 13, 2026 | 1.73 | 1.90 | 1.704 | 1.85 | 422309.0 |
| Aug 12, 2026 | 1.75 | 1.75 | 1.70 | 1.72 | 152064.0 |
| Aug 11, 2026 | 1.78 | 1.78 | 1.69 | 1.73 | 164451.0 |
| Aug 10, 2026 | 1.77 | 1.78 | 1.73 | 1.74 | 228897.0 |
| Aug 07, 2026 | 1.73 | 1.760 | 1.71 | 1.73 | 302254.0 |
| Aug 06, 2026 | 1.62 | 1.69 | 1.602 | 1.69 | 316165.0 |
| Aug 05, 2026 | 1.61 | 1.65 | 1.59 | 1.64 | 318805.0 |
| Aug 04, 2026 | 1.57 | 1.61 | 1.555 | 1.56 | 184297.0 |
| Aug 03, 2026 | 1.52 | 1.58 | 1.482 | 1.56 | 242026.0 |
| Jul 31, 2026 | 1.57 | 1.64 | 1.50 | 1.50 | 506281.0 |
| Jul 30, 2026 | 1.43 | 1.54 | 1.41 | 1.52 | 388436.0 |
| Jul 29, 2026 | 1.50 | 1.569 | 1.41 | 1.43 | 774049.0 |
| Jul 28, 2026 | 1.55 | 1.61 | 1.51 | 1.54 | 235432.0 |
| Jul 27, 2026 | 1.62 | 1.62 | 1.551 | 1.56 | 150113.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| ACADIA Pharmaceuticals, Inc. | 28.91 |
| Alnylam Pharmaceuticals, Inc. | 240.68 |
| Anika Therapeutics, Inc. | 20.64 |
| Savara, Inc. | 5.39 |
| Vericel Corp. | 39.89 |
Price Related Metrics
| Price to Book Value | 1.038 |
| Earnings Yield | -89.76% |
| Market Cap | 89.98M |